Malaria elimination gaining ground in the Asia Pacific by Gosling, Roly D. et al.
Gosling et al. Malaria Journal 2012, 11:346
http://www.malariajournal.com/content/11/1/346COMMENTARY Open AccessMalaria elimination gaining ground in the
Asia Pacific
Roly D Gosling1*, Maxine Whittaker2, Cara Smith Gueye1, Nancy Fullman1, Mario Baquilod3, Rita Kusriastuti4
and Richard GA Feachem1Abstract
Countries in the Asia Pacific region are making substantial progress toward eliminating malaria, but their success
stories are rarely heard by a global audience. “Malaria 2012: Saving Lives in the Asia-Pacific,” a conference hosted by
the Australian Government in Sydney, Australia from October 31 to November 2, 2012, will provide a unique
opportunity to showcase the region’s work in driving down malaria transmission. One of the features of Malaria
2012 will be the Asia Pacific Malaria Elimination Network (APMEN), which has focused on harnessing the collective
experiences of 13 countries through regional political and technical collaboration since its inception in 2009. Run
by country partners, APMEN unites a range of partners – from national malaria programmes and academic
institutions to global and regional policymaking bodies – to support each country’s malaria elimination goals
through knowledge sharing, capacity building, operational research and advocacy.Commentary
Malaria is a global disease, yet knowledge of it outside
sub-Saharan Africa remains limited. As the Asia Pacific
makes great strides toward eliminating malaria, its success
stories are not always heard within the region, let alone
among global audiences [1]. The Asia Pacific Malaria
Elimination Network (APMEN) aims to fill this gap
through regional political and technical collaboration,
harnessing the collective experiences of 13 malaria-
eliminating countries (see Figure 1) and stakeholders to
form a regional initiative to foster information exchange,
evidence generation and advocacy for malaria elimination.
Founded in 2009, APMEN supports malaria prog-
ramme capacity building and works to elevate under-
represented, region-specific issues in the global malaria
arena. Substantial attention is rightfully directed towards
sub-Saharan Africa and Plasmodium falciparum with its
higher malaria morbidity and mortality [2]. Subse-
quently, malaria is often perceived as less problematic in
places like the Asia Pacific. However, the Asia Pacific Re-
gion faces some of the most serious challenges when it
comes to malaria control and elimination. The emer-
gence of P. falciparum artemisinin drug resistance in the* Correspondence: GoslingR@globalhealth.ucsf.edu
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reproduction in any medium, provided the orMekong Region threatens local populations and, if it
spreads, will have serious repercussions around the
globe. Also important is the control of Plasmodium
vivax, a relatively neglected malaria parasite [3]. This
form of malaria is more widespread than P. falciparum
malaria with 2.9 billion people at risk of infection, of
which 90% live in the Asia Pacific [4-7].
APMEN’s Vivax Working Group addresses knowledge
gaps on P. vivax through the initiative’s research grant
programme, capacity-building and research collabora-
tions. This work also aims to augment country
programme capacity in research methods and imple-
mentation, including in-country technical visits. In 2012,
the Working Group launched a multi-center clinical
trials programme for primaquine treatment, and held
workshops on genotyping P. vivax and assessing glu-
cose-6-phosphate dehydrogenase (G6PD) deficiency.
The Asia Pacific’s diversity of malaria vectors (19 dif-
ferent species) poses unique challenges for elimination
because many bite and rest outside [8,9] rendering most
domicile-based interventions, like insecticide-treated
nets and indoor residual spraying, less effective [9,10].
To address these issues, the APMEN Vector Control
Working Group collects, reviews and disseminates the
latest vector control evidence and implementation strat-
egies from the region. With its focus on buildingl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Map of the 13 countries in the Asia Pacific Malaria Elimination Network (APMEN) and when each country joined the network.
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for 2012–2013 and the research agenda includes topics
such as the effectiveness of personal protective methods
for targeted high-risk groups (e.g., rubber tappers, forest
workers).
To further build capacity, APMEN collaboratively
designs and implements training programmes with part-
ners, including the World Health Organization (WHO).
In 2012, these focused on the use of geographic informa-
tion systems for targeting resources and developing
community engagement strategies for malaria elimin-
ation. Each year, APMEN provides funding for five
short-term training opportunities through its Fellowship
programme, allowing Fellows to learn technical skills
from a partner country or institution which then can
be shared with their home malaria programmes. For
example, in 2010 a Fellow from Bhutan Vector-borne
Disease Control Programme was hosted by the Indonesia
National Malaria Control Programme to help improve
strategies for community engagement.
To document programme experiences, share lessons
learnt and determine priorities, APMEN hosts annual
technical meetings and produces a series of country case
studies that report successful approaches and challenges
for malaria elimination [11,12]. During the fourth annual
APMEN meeting in Seoul, held in May 2012, priorities
for the next two years were set that included leveragingAPMEN’s experiences to halt the spread of artemisinin-
resistance by pursuing a P. falciparum-free Mekong
Delta and to solve the challenges of diagnosing and
radically treating P. vivax. Further learning to support
these priorities comes from the cases studies. The first
APMEN case study from Bhutan, demonstrated how
imported malaria from neighbouring high-endemic
countries affects elimination programmes [11]. Ongoing
case studies in Malaysia and the Philippines focus on
using intersectoral collaboration and pursuit of malaria
elimination in a decentralized health system, respect-
ively. The APMEN matrix project, an open access web-
based information exchange promotes sharing of
programme policies with the aim to create an evolving
repository of current elimination strategies and chal-
lenges to inform future research, programme planning
and capacity building in the Asia Pacific.
The most serious threat of resurgent malaria with
subsequent epidemics with high mortality and drug
resistance, most often caused by reductions in malaria
programme financing with scaling-down of control ac-
tivities, must be avoided [13]. As a unified voice advo-
cating for malaria elimination in the region, APMEN
is well positioned to galvanize the crucial political and
financial support to ensure that the gains made in the
fight against malaria are maintained through to elimin-
ation. This regional voice will be heard during the
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ference hosted by the Australian Government in Syd-
ney, Australia October 31st – November 2nd. This
summit will emphasize the importance of regional pol-
itical and technical collaboration to meet control and
elimination targets and to address the challenge of
emerging artemisinin drug resistance. At Malaria 2012,
APMEN will share its experience in unifying and sup-
porting countries in the region fighting to be free of
malaria.
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